Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study

• Published in: Journal of ultrasound in medicine Vol. 34; no. 5; pp. 859 - 867
• Main Authors: Shaw, Colette M, Eisenbrey, John R, Lyshchik, Andrej, O'Kane, Patrick L, Merton, Daniel A, Machado, Priscilla, Pino, Laura, Brown, Daniel B, Forsberg, Flemming
• Format: Journal Article
• Language: English
• Published: England 01.05.2015
• Subjects: Aged; Antineoplastic Agents - administration & dosage; Carcinoma, Hepatocellular - diagnostic imaging; Carcinoma, Hepatocellular - drug therapy; Chemoembolization, Therapeutic - methods; Contrast Media; Delayed-Action Preparations - administration & dosage; Doxorubicin - administration & dosage; Drug-Eluting Stents; Female; Hemostatics - administration & dosage; Humans; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - drug therapy; Male; Middle Aged; Neovascularization, Pathologic - diagnostic imaging; Neovascularization, Pathologic - drug therapy; Observer Variation; Perfusion Imaging - methods; Prognosis; Prospective Studies; Treatment Outcome; Ultrasonography - methods; drug-eluting beads; transarterial chemoembolization; contrast-enhanced ultrasound; hepatocellular carcinoma

To evaluate the accuracy and change over time of contrast-enhanced ultrasound (US) imaging for assessing residual blood flow after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads at 2 different follow-up intervals. Data from 16 tumors treated by transarterial chem...